Patients with melanoma may be interested in participating in a new cancer immunotherapy clinical trial at UVA Health.
Lynn Dengel, MD, will enroll an estimated 11 participants with advanced melanoma to receive focused ultrasound before undergoing standard of care surgery.
“We are hopeful that the… focused ultrasound and the immune-boosting injection into the tumor may bolster the systemic immune response, resulting not only in an effect at the tumor but also stronger long-term protection.”